RACGP and ACRRM collaborating on national rural generalist pathway The RACGP and ACRRM have come together to help develop of a national framework for rural generalism.
Working to cut red tape in general practice The RACGP will address the Senate Red Tape Committee inquiry into Health Services, focusing on a number of key issues for Australian GPs.
Ban on direct-to-consumer advertising by after-hours providers welcomed by RACGP RACGP President Dr Bastian Seidel told newsGP he is pleased with the news after-hours primary care services would no longer be allowed to employ direct-to-consumer advertising.
RACGP appeals for urgent political focus on rising patient costs The RACGP is calling on Australia’s political leaders to develop an immediate solution to patients’ rising out-of-pocket costs.
First issue of Australian Journal of General Practice now available The first issue of the Australian Journal of General Practice, the RACGP’s peer-reviewed scholarly journal, is now available online.
ISQua accredits RACGP Standards for general practices The fifth edition of the RACGP Standards for general practices (the Standards) has been awarded accreditation by the International Society for Quality and Safety in Health Care.
RACGP responds to mid-year economic and fiscal outlook The RACGP has examined key expense measures included in the Federal Government’s 2017–18 mid-year economic and fiscal outlook.
RACGP welcomes free flu vaccinations for NSW children as ‘a step in the right direction’ The RACGP has applauded the NSW Government’s commitment to provide free flu vaccinations to children under the age of five, but wants more to be done to done to protect all Australians against influenza.
New RACGP codeine resource now available The RACGP has created a new online repository to assist GPs in addressing issues relating to the 1 February up-scheduling of codeine.
RACGP flags reservations regarding TGA amendment bills The RACGP is concerned that a Therapeutic Goods Administration list of permitted indications includes numerous ‘traditional’ indications that encourage the pharmaceutical industry to evade products’ scientific proof of efficacy, endorse pseudoscience, and will mislead and confuse consumers.